Related Experiment Video
Updated: Mar 8, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
How Should Remote Clinical Monitoring Be Used to Treat Alcohol Use Disorders?: Initial Findings From an Expert Round
Alan Gordon1, Adi Jaffe, A Thomas McLellan
1Treatment Research Institute (ATM), Philadelphia, PA; Butler Hospital (AG), Providence, RI; Alternatives Behavioral Health (AJ), LLC, Los Angeles, CA; Edgewood Health Network (GR), British Columbia, Canada; Promises Professionals Treatment Program (GS), Santa Monica, CA; Greenberg & Sucher PC (MS), Scottsdale, AZ; ABRI Integrated Health, LLC (CT), Austin; Enterhealth LLC (HCU), Dallas, TX.
Remote blood alcohol content (BAC) monitoring shows promise for alcohol use disorder (AUD) treatment, deterring relapse for at least 12 months. Further research is needed to establish clinical guidelines for its effective use.
Area of Science:
- Addiction Medicine
- Digital Health
- Clinical Research
Background:
- Chronic illness management is increasingly applied to alcohol use disorders (AUDs).
- Remote, real-time monitoring of blood alcohol content (BAC) is now technically feasible.
- Empirical research is lacking to guide the clinical use of remote BAC monitoring in AUD treatment.
Purpose of the Study:
- To discuss key issues in remote BAC monitoring for adults in outpatient AUD treatment.
- To identify areas of consensus and disagreement among experts regarding remote BAC monitoring.
- To inform future clinical and implementation research in this field.
Main Methods:
- An expert panel of clinicians and researchers convened to discuss remote BAC monitoring.
- The panel addressed eight specific issues relevant to outpatient AUD treatment.
- Discussions focused on the clinical viability, relapse deterrence, and intensification of care based on monitoring results.
Main Results:
- Unanimous agreement that 12-month remote BAC monitoring deters relapse in AUD treatment.
- Consensus that positive BAC tests warrant intensified care and monitoring.
- Disagreement on specific methods for clinical intensification following positive tests.
- Agreement on the benefit of sharing results with support groups, but concerns about practicalities.
Conclusions:
- Remote BAC monitoring is a clinically viable tool for relapse prevention in AUD treatment.
- Further clinical and implementation research is essential to develop evidence-based guidelines.
- Addressing practical issues in data sharing is crucial for maximizing the potential of remote monitoring.
More Related Videos
05:12Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
Related Concept Videos
Therapeutic Drug Monitoring: Drug Analysis Methods
Holter Monitor: 24-Hour Monitoring
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Overview and Classification
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...